Therapeutic management of fibrosis in systemic sclerosis patients - an analysis from the Swiss EUSTAR cohort
CONCLUSION: Overall, in Switzerland, a wide range of medications is prescribed for systemic sclerosis patients. This includes modern, targeted treatments for which randomised controlled clinical trial have been recently reported.PMID:38579324 | DOI:10.57187/s.3630
Source: Swiss Medical Weekly - Category: General Medicine Authors: Kevin Windirsch Suzana Jordan Mike Oliver Becker Cosimo Bruni Rucsandra Dobrota Muriel Elhai Ion-Alexandru Garaiman Carmen-Marina Mihai Michele Iudici Paul Hasler Camillo Ribi Britta Maurer Armando Gabrielli Anna-Maria Hoffmann-Vold Oliver Distler Source Type: research
More News: Actemra | Autoimmune Disease | Clinical Trials | CT Scan | General Medicine | Hydroxychloroquine | Interstitial Lung Disease | Jordan Health | Lung Transplant | Methotrexate | Middle East Health | Proton Pump Inhibitors PPIs | Rituxan | Scleroderma | Skin | Stem Cell Therapy | Stem Cells | Study | Switzerland Health | Transplants